Related Experiment Videos

v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell

Christof R Hauck1, Datsun A Hsia, Dusko Ilic

  • 1Department of Immunology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA.

Insights

Viral Src (v-Src) SH3 domain interactions with focal adhesion kinase (FAK) are crucial for cell invasion. Specific mutations disrupt this complex, impairing invasion, but FAK re-expression restores it, highlighting FAK

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Virology

Background:

  • Viral Src (v-Src) protein kinase is a potent oncogene.
  • Focal Adhesion Kinase (FAK) is a key regulator of cell motility and invasion.
  • v-Src and FAK form signaling complexes that influence cell behavior.

Purpose of the Study:

  • To investigate the role of the v-Src SH3 domain, specifically the Arg-95 to Trp mutation, in v-Src-mediated cell invasion.
  • To determine the significance of v-Src and FAK complex stability in invadopodia for cell invasion.
  • To elucidate the contribution of FAK to v-Src-induced cell invasion.

Main Methods:

  • Comparison of wild-type v-Src and a v-Src SH3 domain mutant (v-Src-RT) in Src-/- fibroblasts.
  • Assessment of cell motility, growth, invasion through Matrigel, and signaling complex formation.
  • Utilizing adenovirus-mediated FAK overexpression and inhibition to study FAK's role.

Main Results:

  • The v-Src SH3 domain mutation (v-Src-RT) reduced v-Src-FAK complex stability and FAK phosphorylation.
  • v-Src, but not v-Src-RT, promoted cell invasion and co-localized with FAK and β1 integrin at invadopodia.
  • FAK overexpression rescued the invasion defect of v-Src-RT, while FAK inhibition blocked v-Src-induced invasion.

Conclusions:

  • Gain-of-function v-Src SH3 domain interactions with FAK at β1 integrin-containing invadopodia stabilize the v-Src-FAK complex.
  • This stabilized complex is essential for promoting v-Src-mediated cell invasion.
  • Targeting these specific interactions could offer therapeutic strategies against v-Src-driven cancers.

Related Concept Videos